Interní Med. 2005; 7(5): 219-222

Cardioprotection

doc. MUDr. Jiří ©pác CSc
II. interní klinika FN u sv. Anny LF MU, Brno

The goal of treatment of coronary heart disease is relief of symptoms and cardioprotection., i.e. measures leading to protection of myocardium and decrease or prevention of cardiac damage and improvement of prognosis. Cardioprotection is a general pathophysiologic term including protection of myocardial cells from the damage by ischemia and consequent impairment by reperfusion, inflammation, hypertension and toxic and degenerative changes including several types of apoptosis. Cardioprotection has many specific forms in clinical practice, different in acute situation, different in chronic patients or in patients with subclinical atherosclerosis (tab 1).

Keywords: Key words: Coronary heart disease, therapy, secondary prevention.

Published: January 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
©pác J. Cardioprotection. Interní Med. 2005;7(5):219-222.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Gottlieb SS, McCarter RJ, Vogel RA. Effect of Beta-Blockade on Mortality among High-Risk and Low-Risk Patients after Myocardial Infarction.
    2. Hoffman BB. Adrenoreceptor-blocking drugs. In: Katzung BG (ed). Clinical Pharmacology. Norwalk, CT, Appleton and Lange, 1994: 131-146.
    3. Chandrashekhar Y, Sen S, Anway R, Shuros A, Anand I. Long-Term caspase inhibition ameliorates apoptosis, reduces myocardial troponin-I cleavage, protects left ventricular function, and attenuates remodeling in rats with myocardial infarction. JACC, 2004; 43, 2: 295-301. Go to original source... Go to PubMed...
    4. Kloner RA, Shook T, Antman EM, et al. Prospective temporal analysis of the onset of preinfarction angina versus outcome: An ancillary study in TIMI 9B. Circulation 1998; 97: 1042-1045. Go to original source... Go to PubMed...
    5. Murray CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124-1136. Go to original source... Go to PubMed...
    6. Pier D. Lambiase, Richard J. Edwards, Michael R. Cusack, Clifford A. Bucknall, Simon R. Redwood, Michael S. Marber Exercise-induced ischemia initiates the second window of protection in humans independent of collateral recruitment. JACC, 2003; 41, 7: 1174-1182. Go to original source... Go to PubMed...
    7. Salpeter SR, Ormiston TM, Salpeter EE. (2002). Cardioselective ?-Blockers in Patients with Reactive Airway Disease: A Meta-Analysis. Ann Intern Med, 2002; 137: 715-725. Go to original source... Go to PubMed...
    8. Shinmura K, Kodani E, Xuan YT, Dawn B, Tang XL, Bolli R. Effect of aspirin on late preconditioning against myocardial stunning in conscious rabbits, JACC, 2003; 41, 7: 1183-1194. Go to original source... Go to PubMed...
    9. Szwed H, Sadowski Z, Elikowski W, Koronkiewicz A, Mamcarz A, Orszulak W, Skibinska E, Szymczak K, Swiatek J, Winter M. Combination treatment in stable effort angina using trimetazidine and metoprolol. Results of a randomized, double-blind, multicentre study (TRIMPOL II). European Heart Journal, 2001; 22, 24: 2267-2274. Go to original source... Go to PubMed...
    10. The CREATE-ECLA Trial Group Investigators. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction. JAMA 2005; 293: 437-446. Go to original source... Go to PubMed...
    11. Verma S, Fedak PWM, Weisel RD, Butany J, Rao V, Maitland A, Li RK, Dhillon B, Yau TM. Fundamentals of reperfusion injury for the clinical cardiologist. Circulation, 2002; 105: 2332-2336. Go to original source... Go to PubMed...
    12. Wallhaus TR, Taylor M, DeGrado TR, et al. Myocardial free fatty acid and glucose use after carvedilol treatment in patients with congestive heart failure. Circulation, 2001; 103, 20: 2441-2446. Go to original source... Go to PubMed...
    13. Yusuf S. Two decades of progress in preventing vascular disease Lancet, 2002; 360, 9326: 2-3. Go to original source... Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.